Panagora Asset Management Inc Care Dx, Inc. Transaction History

Panagora Asset Management Inc

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$20.49 - $39.72 $215,903 - $418,529	-10,537 Closed	0 $0
Q4 2021 Feb 10, 2022	BUY	$41.2 - $73.6 $184,164 - $328,992	4,470 Added 73.68%	10,537 $479,000
Q2 2021 Aug 11, 2021	SELL	$63.02 - $95.11 $84,383 - $127,352	-1,339 Reduced 18.08%	6,067 $555,000
Q1 2021 May 12, 2021	BUY	$57.62 - $95.6 $426,733 - $708,013	7,406 New	7,406 $504,000
Q4 2020 Feb 10, 2021	SELL	$41.43 - $77.09 $47,313 - $88,036	-1,142 Closed	0 $0
Q1 2020 May 14, 2020	BUY	$13.94 - $28.25 $2,885 - $5,847	207 Added 22.14%	1,142 $25,000
Q4 2019 Feb 12, 2020	BUY	$19.24 - $28.41 $17,989 - $26,563	935 New	935 $20,000
Q1 2019 May 15, 2019	SELL	$22.09 - $39.21 $1,678 - $2,979	-76 Closed	0 $0
Q3 2018 Nov 13, 2018	SELL	$12.1 - $28.85 $62,242 - $148,404	-5,144 Reduced 98.54%	76 $2,000
Q2 2018 Aug 14, 2018	SELL	$7.93 - $15.79 $128,688 - $256,240	-16,228 Reduced 75.66%	5,220 $64,000
Q4 2017 Feb 14, 2018	SELL	$3.98 - $7.37 $81,737 - $151,357	-20,537 Reduced 48.92%	21,448 $157,000
Q3 2017 Nov 14, 2017	BUY	$1.33 - $4.12 $55,840 - $172,978	41,985	41,985 $155,000

218

51.1M

97.3K

43.3K

Ticker CDNA
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 53,458,100
Market Cap $1.12B
Description
CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for...

Get notified when there are updates to the investment portfolio of Panagora Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Panagora Asset Management Inc with notifications on news.